Garofalo L, Cuello A C
Department of Pharmacology and Therapeutics, McGill University, Montreal, Quebec, Canada.
Exp Neurol. 1994 Feb;125(2):195-217. doi: 10.1006/exnr.1994.1024.
This study examined the behavioral effects of maximal doses of exogenous NGF and/or GM1 when given intracerebroventricularly to adult rats with unilateral cortical lesions. In addition, the long-term effects of these agents on choline acetyltransferase (ChAT), glutamic acid decarboxylase (GAD) activity, and choline uptake, as well as on ChAT and NGF receptor (p75NGFR) immunoreactivity in various brain regions, were also investigated. When retested in passive avoidance and Morris water maze tasks, 30 days postlesion (i.e., 2 weeks after termination of treatment), decorticated vehicle-treated rats showed retention and reacquisition deficits which were equally attenuated by NGF (6 micrograms/day, 14 days) or NGF + GM1 (750 micrograms/day, 14 days) treatment. By contrast, lesioned animals which received GM1 alone only showed improved reacquisition of the two tasks. After behavioral testing (52 days postlesion) lesioned vehicle-treated animals had decreased ChAT activity in the ipsilateral nucleus basalis magnocellularis (NBM) but not in other subcortical brain areas examined. Neuronal loss was observed only in the ventrolateral nucleus of the ipsilateral dorsal thalamus. However, using quantitative image analysis a significant shrinkage of ChAT immunoreactive (IR) and p75NGFR-IR NBM neurons as well as a decrease in their neuritic network was noted, particularly in the mid portion of the NBM. GM1 and NGF equally prevented these deficits in the NBM and, furthermore, enhanced ChAT activity and choline uptake in the remaining cortex ipsilateral to the lesion site. These alterations in NBM and cortical cholinergic markers were even more augmented in rats which received both NGF and GM1 treatment. By contrast, the noted NGF-induced increase in striatal ChAT activity was not further increased by concomitant GM1 treatment. GAD activity in all brain areas examined was unaltered by the lesion or any of the treatments and the apparent thalamic neuronal retrograde degeneration was not prevented by any of the treatments. It is concluded that GM1 or NGF treatment can distinctly affect performance of cortically lesioned rats in passive avoidance and Morris water maze tasks despite their equal ability to serve as long-term neuroprotective agents for the basalo-cortical cholinergic pathway.
本研究检测了向单侧皮质损伤的成年大鼠脑室内注射最大剂量外源性神经生长因子(NGF)和/或神经节苷脂(GM1)后的行为学效应。此外,还研究了这些药物对胆碱乙酰转移酶(ChAT)、谷氨酸脱羧酶(GAD)活性、胆碱摄取的长期影响,以及对不同脑区ChAT和NGF受体(p75NGFR)免疫反应性的长期影响。在损伤后30天(即治疗终止后2周)对被动回避和Morris水迷宫任务进行重新测试时,接受赋形剂治疗的去皮质大鼠表现出记忆保持和重新习得缺陷,NGF(6微克/天,共14天)或NGF + GM1(750微克/天,共14天)治疗可同等程度地减轻这些缺陷。相比之下,仅接受GM1治疗的损伤动物仅在两项任务的重新习得方面有所改善。行为测试后(损伤后52天),接受赋形剂治疗的损伤动物同侧基底大细胞核(NBM)中的ChAT活性降低,但在所检测的其他皮质下脑区未降低。仅在同侧背侧丘脑腹外侧核观察到神经元丢失。然而,通过定量图像分析发现,ChAT免疫反应性(IR)和p75NGFR-IR NBM神经元显著萎缩,其神经突网络减少,特别是在NBM的中部。GM1和NGF同样可预防NBM中的这些缺陷,此外,还可增强损伤部位同侧剩余皮质中的ChAT活性和胆碱摄取。在同时接受NGF和GM1治疗的大鼠中,NBM和皮质胆碱能标志物的这些改变更为明显。相比之下,GM1联合治疗并未进一步增加NGF诱导的纹状体ChAT活性升高。在所检测的所有脑区中,GAD活性未因损伤或任何一种治疗而改变,且任何一种治疗均未预防明显的丘脑神经元逆行性变性。得出的结论是,尽管GM1或NGF作为基底-皮质胆碱能通路的长期神经保护剂的能力相同,但它们对皮质损伤大鼠在被动回避和Morris水迷宫任务中的表现有明显不同的影响。